Oxidative modification of low‐density lipoproteins and the inhibition of relaxations mediated by endothelium‐derived nitric oxide in rabbit aorta
Open Access
- 1 January 1992
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 105 (1), 216-222
- https://doi.org/10.1111/j.1476-5381.1992.tb14237.x
Abstract
1 The mechanism by which Cu2+-oxidized low-density lipoproteins (oxLDL) inhibit acetylcholine (ACh)-evoked relaxations mediated by endothelium-derived nitric oxide (EDRF) in rabbit aortic rings was investigated. The proposed role of lysophosphatidylcholine (LPC) in the inhibition was also studied. 2 The kinetics of lipid peroxidation of native low-density lipoproteins (LDL) from individual donors, as measured by changes in conjugated diene concentration, were related to the inhibitory effects of the resultant oxLDL. It was found that the more susceptible LDL was to oxidation, the greater the inhibition. 3 No correlation was found between the inhibitory effects of oxLDL and LPC content. 4 Synthetic 1-palmitoyl LPC produced an inhibition of ACh-induced relaxations and when added to precontracted rings evoked nitric oxide-mediated endothelium-dependent relaxation. This latter effect was not elicited by oxLDL. 5 Synthetic 1-palmitoyl (10 μm) had no effect on relaxations evoked by glyceryl trinitrate in endothelium-denuded aortic rings in contrast to the inhibition found previously for oxLDL. 6 Concentrations of oxLDL and phospholipase A2-treated LDL which inhibited relaxation contained very different LPC concentrations. Unlike oxLDL, the inhibitory effects of phospholipase A2-treated LDL preparations were independent of the donors and showed no lag period. 7 We sugggest that there are differences in the mechanisms by which oxLDL and 1-palmitoyl LPC exert their inhibitory effects on relaxation. 8 The inhibition of relaxation by oxLDL (1–2 mg protein ml−1) was prevented by the presence of high-density lipoproteins (HDL; 1–2 mg protein ml−1). 9 It is proposed that prevention of the inhibition of relaxation by HDL is consistent with the inhibitory factor(s) being lipophilic constituents of oxLDL. However, variations in the inhibitory effects of oxLDL preparations are not due to differences in their LPC content and factors other than LPC must contribute to the inhibition.Keywords
This publication has 25 references indexed in Scilit:
- Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Lysophosphatidylcholine: Essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoproteinBiochemical and Biophysical Research Communications, 1990
- Biochemical structural and functional properties of oxidized low-density lipoproteinChemical Research in Toxicology, 1990
- Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteinsNature, 1990
- Beyond CholesterolNew England Journal of Medicine, 1989
- Continuous Monitoring ofin VztroOxidation of Human Low Density LipoproteinFree Radical Research Communications, 1989
- Low-density lipoprotein concentration in interstitial fluid from human atherosclerotic lesionsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983
- Lipoprotein oxidation and lipoprotein-induced cytotoxicity.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983
- LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in cultureAtherosclerosis, 1979
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959